BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21251859)

  • 21. Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands.
    Klopfleisch R; Gruber AD
    Res Vet Sci; 2009 Aug; 87(1):91-6. PubMed ID: 19185891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased Derlin-1 expression in metastases of canine mammary adenocarcinomas.
    Klopfleisch R; Schütze M; Linzmann H; Brunnberg L; Gruber AD
    J Comp Pathol; 2010 Jan; 142(1):79-83. PubMed ID: 19632687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P-glycoprotein expression in canine mammary gland tumours related with myoepithelial cells.
    Kim NH; Hwang YH; Im KS; Kim JH; Chon SK; Kim HY; Sur JH
    Res Vet Sci; 2012 Dec; 93(3):1346-52. PubMed ID: 22554937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-associated carbohydrate antigens: Sialyl Lea and T/Tn antigens in canine mammary tumors.
    Nowak M; Madej J; Dziegiel P; Lopuszynski W; Rodo A; Ugorski M
    Vet Pathol; 2009 Mar; 46(2):222-6. PubMed ID: 19261632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer.
    Klopfleisch R; Hvid H; Klose P; da Costa A; Gruber AD
    Vet Comp Oncol; 2010 Dec; 8(4):293-301. PubMed ID: 21062411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical expression of p63 protein and calponin in canine mammary tumours.
    Łopuszyński W; Szczubiał M; Millán Y; Guil-Luna S; Sánchez-Céspedes R; Martin de Las Mulas J; Śmiech A; Bulak K
    Res Vet Sci; 2019 Apr; 123():232-238. PubMed ID: 30685648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COX-2 expression in canine normal and neoplastic mammary gland.
    Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
    Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
    J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of VEGF-C expression in canine mammary tumours.
    Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
    Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors.
    Rao NA; van Wolferen ME; Gracanin A; Bhatti SF; Krol M; Holstege FC; Mol JA
    J Physiol Pharmacol; 2009 May; 60 Suppl 1():73-84. PubMed ID: 19609016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The myoepithelial cell: its role in normal mammary glands and breast cancer.
    Sopel M
    Folia Morphol (Warsz); 2010 Feb; 69(1):1-14. PubMed ID: 20235044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
    Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
    Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caveolin-1 in diagnosis and prognosis of canine mammary tumours: comparison of evaluation systems.
    Pereira PD; Lopes CC; Matos AJ; Cortez PP; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2010; 143(2-3):87-93. PubMed ID: 20153868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
    Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
    Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in indicators of malignancy between luminal epithelial cell type and myoepithelial cell type of simple solid carcinoma in the canine mammary gland.
    Yoshimura H; Nakahira R; Kishimoto TE; Michishita M; Ohkusu-Tsukada K; Takahashi K
    Vet Pathol; 2014 Nov; 51(6):1090-5. PubMed ID: 24448671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel myoepithelial cell marker in canine mammary tissue.
    Gama A
    Vet J; 2011 Dec; 190(3):303-4. PubMed ID: 21640620
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
    Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
    Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study.
    Dias Pereira P; Carvalheira J; Gärtner F
    Vet J; 2004 Sep; 168(2):180-5. PubMed ID: 15301767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the plasma membrane markers aquaporin 1 (AQP1), glucose transporter 1 (GLUT1) and Na, K-ATPase in canine mammary glands and mammary tumours.
    Freeman A; Hetzel U; Cripps P; Mobasheri A
    Vet J; 2010 Jul; 185(1):90-3. PubMed ID: 20570191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of CD10 as a marker of canine mammary myoepithelial cells.
    Sánchez-Céspedes R; Suárez-Bonnet A; Millán Y; Guil-Luna S; Reymundo C; Herráez P; Espinosa de Los Monteros A; Martin de Las Mulas J
    Vet J; 2013 Feb; 195(2):192-9. PubMed ID: 22819182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.